Griffin Securities Positive on MannKind (MNKD) as Afrezza Debuts; Sanofi Believed to Have Dedicated 1,500 Sales Reps
Tweet Send to a Friend
Griffin Securities analyst Keith Markey weighed in on MannKind (NASDAQ: MNKD) after the company and Sanofi announced the official launch ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
